Lifecore Biomedical, Inc. De (LFCR) Assets (2011 - 2025)

Lifecore Biomedical has reported Assets for 15 years, with the latest figure at $239.3 million in Q2 2025.

• On a quarterly basis, Assets fell 5.76% year-over-year to $239.3 million in Q2 2025; TTM through May 2025 was $239.3 million, a 5.76% decrease from a year earlier, with the FY2025 full-year figure at $239.3 million, down 5.76% from the prior year.
• Assets was $239.3 million for Q2 2025 at Lifecore Biomedical, up from $237.7 million in the prior quarter.
• The five-year high for Assets was $506.9 million in Q1 2021, with the low at $236.7 million in Q1 2023.
• Average Assets over 5 years is $304.3 million, with a median of $254.7 million recorded in 2024.
• The sharpest annual moves came in 2021 and 2022: Assets surged 71.0% in 2021, then sank 45.27% in 2022.
• Over 5 years, Assets stood at $421.3 million in 2021, then tumbled by 34.5% to $276.0 million in 2022, then slipped by 10.93% to $245.8 million in 2023, then climbed by 3.89% to $255.4 million in 2024, then decreased by 6.28% to $239.3 million in 2025.
• The last three Assets figures came in at $239.3 million (Q2 2025), $237.7 million (Q1 2025), and $255.4 million (Q4 2024), per Business Quant data.